Tandem Diabetes Care, Inc. TNDM posted a third-quarter 2024 loss of 36 cents per share compared with the year-ago quarter’s ...

Canaccord Genuity Group currently has a buy rating on the medical device company’s stock. A number of other equities research ...

On Friday, Tandem Diabetes Care Inc (TNDM) stock saw a decline, ending the day at $30.6 which represents a decrease of $-2.72 or -8.16% from the prior close of $33.32. The stock opened at $33.71 and ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Waters (WAT – Research Report), Pharvaris ...

Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) were down 9.6% on Friday after Canaccord Genuity Group lowered their price target on the stock from $57.00 to $56.00. Canaccord ...

Tandem Diabetes Care shares ticked up after hours today on third-quarter results that topped the consensus forecast.

Bernstein has recently initiated Tandem Diabetes Care Inc (TNDM) stock to Outperform rating, as announced on Today, according to Finviz. Earlier, on October 4, 2024, Goldman had initiated the stock to ...

Tandem Diabetes Care (TNDM) and Insulet (PODD) stocks draw outperform ratings at Bernstein as insulin pump makers prepare for ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

TANDEM DIABETES CARE INC (TNDM) is a mid-cap growth stock in the Medical Equipment & Supplies industry. The rating using this strategy is 55% based on the firm’s underlying fundamentals and the ...

Short interest in Tandem Diabetes Care Inc (NASDAQ:TNDM) decreased during the last ... betting on the decline of Tandem Diabetes Care's stock. Short interest data is updated every two weeks.